Status:
COMPLETED
Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects
Lead Sponsor:
Bausch Health Americas, Inc.
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.
Eligibility Criteria
Inclusion
- Generally healthy subjects men or women aged 18-50
Exclusion
- Any significant clinically important disease
- Family history of long QT syndrome and/or sudden cardiac death
- Allergy to moxifloxacin or the quinolone class of antibiotics
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
October 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00434395
Start Date
March 1 2007
End Date
October 1 2007
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix, Arizona, United States, 85044